Selva Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- July 21, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $3,000,000
Company Info
- Company Description
- Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases. The company's lead drug candidate, SLV213, is an orally available small molecule novel antiviral therapy with activity against a broad range of viruses that threaten global health, including SARS-CoV-2, the virus causing COVID-19.
- Market
- Infectious Diseases
- Location
- San Diego, CA, USA